article thumbnail

FDA releases analysis on drug product quality in 2022

European Pharmaceutical Review

The most cited CGMP issues in FY2022 by FDA across all warning letters were related to: Quality control unit Production record review/investigations Written procedures/deviations Equipment cleaning and maintenance Testing/release. FDA’s sampling and testing programme found 892 of 1,552 product samples (57.5

article thumbnail

How Medical Reps Influence Prescriptions in Underserved Regions

Contrarian Sales Techniques

By providing detailed information, product samples, and support, reps help bridge the knowledge gap and influence prescribing habits. Final Thought Pharma sales in underserved regions isn’t just about selling medicines – it’s about being part of the solution. This is where medical reps step in.